{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:02:30Z","timestamp":1789851750309,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012156","name":"Shenzen Municipal Technical Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Municipal Fundamental Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tranon.2026.102842","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:08:39Z","timestamp":1781784519000},"page":"102842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PUM2 inhibits ferroptosis and enhances oxaliplatin resistance in COAD via the NEDD4L\/NRF2 axis"],"prefix":"10.1016","volume":"71","author":[{"given":"Jiacheng","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102842_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102842_bib0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.tranon.2026.102842_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179463","article-title":"From crypts to cancer: a holistic perspective on colorectal carcinogenesis and therapeutic strategies","volume":"25","author":"Gharib","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102842_bib0004","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2026.102842_bib0005","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ajpath.2017.06.010","article-title":"Early actions of anti\u2013vascular endothelial growth factor\/vascular endothelial growth factor receptor drugs on angiogenic blood vessels","volume":"187","author":"Sitohy","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tranon.2026.102842_bib0006","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and emerging therapeutic approaches for colorectal cancer: a comprehensive review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"10.1016\/j.tranon.2026.102842_bib0007","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S1470-2045(14)70486-3","volume":"15","author":"Schmoll","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2026.102842_bib0008","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1200\/JCO.23.01889","article-title":"Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase III optical trial","volume":"42","author":"Hu","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102842_bib0009","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/annonc\/mdw191","article-title":"Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory","volume":"27","author":"Sartore-Bianchi","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.102842_bib0010","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3748\/wjg.v24.i34.3834","article-title":"Drug resistance and new therapies in colorectal cancer","volume":"24","author":"Van der Jeught","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2026.102842_bib0011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2026.102842_bib0012","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tranon.2026.102842_bib0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.tranon.2026.102842_bib0014","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.tranon.2026.102842_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2026.102842_bib0016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","article-title":"CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.102842_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113110","article-title":"AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis","volume":"42","author":"Lei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.102842_bib0018","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41419-024-06914-0","article-title":"BUB1b impairs chemotherapy sensitivity via resistance to ferroptosis in lung adenocarcinoma","volume":"15","author":"Ding","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2026.102842_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101240","article-title":"Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer","volume":"81","author":"Lin","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tranon.2026.102842_bib0020","article-title":"Inhibition of CDK1 overcomes oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in colorectal cancer","volume":"10","author":"Zeng","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tranon.2026.102842_bib0021","first-page":"1855","article-title":"PUM2, a novel murine puf protein, and its consensus RNA-binding site","volume":"7","author":"White","year":"2001","journal-title":"RNA"},{"key":"10.1016\/j.tranon.2026.102842_bib0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1247\/csf.18030","article-title":"PUM2 promotes glioblastoma cell proliferation and migration via repressing BTG1 expression","volume":"44","author":"Wang","year":"2019","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.tranon.2026.102842_bib0023","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41467-022-29309-1","article-title":"PUMILIO proteins promote colorectal cancer growth via suppressing p21","volume":"13","author":"Gong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102842_bib0024","first-page":"1421","article-title":"The pumilio protein binds RNA through a conserved domain that defines a new class of RNA-binding proteins","volume":"3","author":"Zamore","year":"1997","journal-title":"RNA"},{"key":"10.1016\/j.tranon.2026.102842_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70388","article-title":"IGF2BP2 binding to CPSF6 facilitates m6A-mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer","volume":"15","author":"Luo","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tranon.2026.102842_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030636","article-title":"NORAD-regulated signaling pathways in breast cancer progression","volume":"16","author":"Capela","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102842_bib0027","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2022.13466","article-title":"RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3\u2019UTR of BTG3","volume":"24","author":"Liu","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2026.102842_bib0028","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00018-025-05599-8","article-title":"RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting with transcription factor EGR1","volume":"82","author":"Bangbo","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tranon.2026.102842_bib0029","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","article-title":"The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy","volume":"45","author":"Jiang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tranon.2026.102842_bib0030","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s41388-025-03337-9","article-title":"CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3\/NRF2\/GPX2 axis","volume":"44","author":"Bai","year":"2025","journal-title":"Oncogene"},{"issue":"Suppl 3","key":"10.1016\/j.tranon.2026.102842_bib0031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1463-1318.5.s3.3.x","article-title":"The evolving role of oxaliplatin in the management of colorectal cancer","volume":"5","author":"de Gramont","year":"2003","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.tranon.2026.102842_bib0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12916-023-02826-6","article-title":"Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3\/AR\/RASGRP3 axis","volume":"21","author":"Zheng","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.tranon.2026.102842_bib0033","first-page":"88","article-title":"Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a north central cancer treatment group review of 3811 patients, n0144","volume":"8","author":"Dy","year":"2009","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.tranon.2026.102842_bib0034","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.102842_bib0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00018-023-04907-4","article-title":"Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance","volume":"80","author":"Ren","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tranon.2026.102842_bib0036","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-025-08020-1","article-title":"JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer","volume":"16","author":"Shu","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2026.102842_bib0037","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.freeradbiomed.2025.09.002","article-title":"LncRNA BASP1-AS1 drives PCBP2 K115 lactylation to suppress ferroptosis and confer oxaliplatin resistance in gastric cancer","volume":"240","author":"Zhao","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tranon.2026.102842_bib0038","article-title":"MAPK signaling-mediated RFNG phosphorylation and nuclear translocation restrain oxaliplatin-induced apoptosis and ferroptosis","volume":"11","author":"Di","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tranon.2026.102842_bib0039","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10495-026-02308-z","article-title":"Nicotine suppresses ferroptosis in colon cancer cells via HMOX1\/NF-\u03baB pathway to reduce oxaliplatin sensitivity","volume":"31","author":"Xu","year":"2026","journal-title":"Apoptosis"},{"key":"10.1016\/j.tranon.2026.102842_bib0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cac2.12417","article-title":"Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer","volume":"43","author":"Guo","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.tranon.2026.102842_bib0041","article-title":"The E3 ligase NEDD4L prevents colorectal cancer liver metastasis via degradation of PRMT5 to inhibit the AKT\/mTOR signaling pathway","volume":"12","author":"Dong","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tranon.2026.102842_bib0042","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41467-022-29309-1","article-title":"PUMILIO proteins promote colorectal cancer growth via suppressing p21","volume":"13","author":"Gong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102842_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102112","article-title":"Oxaliplatin retreatment in metastatic colorectal cancer: systematic review and future research opportunities","volume":"91","author":"Mauri","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tranon.2026.102842_bib0044","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2165\/00003495-200363190-00013","article-title":"Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer","volume":"63","author":"Simpson","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.tranon.2026.102842_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1231401","article-title":"Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tranon.2026.102842_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:22:11Z","timestamp":1789849331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S1936523326001798"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102842","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PUM2 inhibits ferroptosis and enhances oxaliplatin resistance in COAD via the NEDD4L\/NRF2 axis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102842"}}